Survival in patients with implantable cardioverter defibrillator indication in single-center trial 5 years follow-up

Wenqing Zhu,Jin Bai,Wei Wang,Yan Wu,Yangang Su,Junbo Ge
DOI: https://doi.org/10.3760/cma.j.issn.1007-6638.2015.01.008
2015-01-01
Abstract:Objective To compare the outcome of 5-year survival in implantable cardioverter defibril-lator(ICD)indication patients with or without ICD/cardiac resynchronization therapy-defibrillator(CRT-D)im-plantation. Method Patients with ICD indication were consecutively recruited. The basic information,examina-tion results and treatment state were recorded. We got the information of vicious incidents or death of the pa-tients mainly by telephone. Results One hundred fifhy-two patients were enrolled for the study. Twenty six pa-tients were undergoing implantation, including 11 for primary and 15 for secondary prevention ( 9. 3% vs. 44. 1% P<0. 001). Twenty three patients missed and 33 patients died during 5-year follow-up. All-cause mor-tality in patients with ICD implantation was significant lower than that in patients without ICD implantation (7. 7% vs. 30. 1% P=0. 016). While the survival curve did not show statistical difference(P=0. 09). Logis-tic regression shown that left ventricular ejection fraction( LVEF) and ICD/CRT-D implantation both had a posi-tive correlation with survival rate(P=0. 01 and P=0. 015). Conclusion ICD/CRT-D can improve the long-term survival rate in patients with ICD indication. LVEF is a sensitive predictor for 5-year survival rate.
What problem does this paper attempt to address?